Liver Diseases and Immunity
Liver Diseases and Immunity is a research topic within Hepatology. Science Explorer counts 21k research works in it since 1950. 17.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, management, epidemiology, and genetic factors of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. It also covers topics such as liver transplantation, immunosuppressive therapy, and the pathogenesis of these liver diseases.
- Autoimmune Hepatitis
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
- Diagnosis
- Management
- Epidemiology
- Genome-wide Association Study
- Liver Transplantation
- Immunosuppressive Therapy
- Pathogenesis
- Research works
- 21k fractional, since 1950
- In the world top 10%
- 3.8k per year above
- Top-10% rate
- 17.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Liver Diseases and Immunity research?
By volume, China and the United States publish the most (845 and 789 works in 2022–2025).
By volume, 2022–2025
- 1 China 845 works
- 2 United States 789 works
- 3 Japan 217 works
- 4 India 180 works
- 5 Germany 176 works
- 6 Italy 174 works
- 7 United Kingdom 169 works
- 8 Spain 119 works
- 9 France 102 works
- 10 Canada 89 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Liver Diseases and Immunity research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Liver Diseases and Immunity research, followed by Capital Medical University and University of Padua.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
- 2 Capital Medical UniversityChina 16 works
- 3 University of PaduaItaly 14 works
- 4 Sun Yat-sen UniversityChina 14 works
- 5 Peking UniversityChina 14 works
- 6 Huazhong University of Science and TechnologyChina 12 works
- 7 Icahn School of Medicine at Mount SinaiUnited States 12 works
- 8 Mayo ClinicUnited States 12 works
- 9 Sichuan UniversityChina 11 works
- 10 Yale UniversityUnited States 11 works
Who are the leading researchers in Liver Diseases and Immunity?
The most-cited researchers publishing on Liver Diseases and Immunity include Winfried März and Alejandro Forner.
- 1 Winfried März Germany 5.2k citations
- 2 Alejandro Forner Spain 3.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Liver Diseases and Immunity research done?
The largest centres of Liver Diseases and Immunity research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and London (United Kingdom).
Where is the best place to study Liver Diseases and Immunity?
Among universities, judged by research, Medical University of Vienna, Shanghai University of Traditional Chinese Medicine and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of ViennaAustria | 61.3 | 32.6% | 8.2× | 10 | +67.3% |
| 2 | Shanghai University of Traditional Chinese MedicineChina | 57.6 | 37.8% | 11.3× | 9 | +30.6% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.0 | 27.1% | 4.4× | 17 | +51.9% |
| 4 | University of PaduaItaly | 53.6 | 22.9% | 4.5× | 14 | +97.3% |
| 5 | Icahn School of Medicine at Mount SinaiUnited States | 51.6 | 25.7% | 6.4× | 12 | +38.7% |
| 6 | Capital Medical UniversityChina | 50.3 | 16.3% | 7.0× | 16 | +8.4% |
| 7 | Medizinische Hochschule HannoverGermany | 49.3 | 22.7% | 11.3× | 10 | -13.1% |
| 8 | Karolinska InstitutetSweden | 49.3 | 30.7% | 5.2× | 9 | +29.9% |
| 9 | University of California San DiegoUnited States | 48.2 | 41.1% | 2.7× | 9 | +84.5% |
| 10 | Nanjing Medical UniversityChina | 47.7 | 27.4% | 4.6× | 9 | +280.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Liver Diseases and Immunity research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Liver Diseases and Immunity.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.